|

Lumateperone Clinical Trials

2 actively recruiting trials across 2 locations

No change since June 2026

Pipeline

Phase 3: 2

Top Sponsors

  • Intra-Cellular Therapies, Inc.2

Indications

  • Depression2
  • Bipolar Depression1
  • Major Depressive Disorder1

Dothan, Alabama1 trial

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

Harmonex Neuroscience Research

Phase 3

Huntsville, Alabama1 trial

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

University of Alabama at Birmingham

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.